A Randomized, Doubleblind, Placebo-Controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Progressive Pulmonary Fibrosis (TETON-PPF)

Grants and Contracts Details

StatusActive
Effective start/end date5/14/24 → 5/14/26

Funding

  • United Therapeutics Corporation: $11,193.00